Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear genomic DNA is the primary repository of genetic information within a cell. It serves as the template for replication and transcription, essential processes for cell survival and proliferation. Carboplatin targets DNA by forming covalent adducts, disrupting these processes and leading to cell death, particularly in rapidly dividing cancer cells.
Forms platinum-DNA adducts leading to DNA crosslinking, inhibiting replication and transcription.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear Genomic DNA (DNA).